欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2019, Vol. 24 ›› Issue (4): 451-457.doi: 10.12092/j.issn.1009-2501.2019.04.014

• 药物治疗学 • 上一篇    下一篇

比索洛尔联合丹参多酚酸盐对冠心病PCI术后患者的疗效分析

陈 苗,张新金,孟红丽,杨 蓓,宋丽娟,邹川南,关英霞   

  1. 云南省第二人民医院心内科,昆明 650000,云南
  • 收稿日期:2018-12-24 修回日期:2019-04-04 出版日期:2019-04-26 发布日期:2019-05-01
  • 作者简介:陈苗,女,主治医师,硕士研究生,研究方向:心血管疾病。 Tel:15887825419 E-mail:chenmiao_1984@163.com
  • 基金资助:

    云南省科技计划项目[2017FE4689(-083)]

Therapeutic effect of bisoprolol combined with salvianolate on patients with coronary heart disease after PCI

CHEN Miao, ZHANG Xinjin, MENG Hongli, YANG Bei, SONG Lijuan, ZOU Chuannan, GUAN Yingxia   

  1. Department of Cardiology, Second People's Hospital of Yunnan Province, Kunming 650000, Yunnan, China
  • Received:2018-12-24 Revised:2019-04-04 Online:2019-04-26 Published:2019-05-01

摘要:

目的:分析比索洛尔联合丹参多酚酸盐对冠心病经皮冠状动脉介入(percutaneous transluminal coronary intervention,PCI)术后患者微炎环境、血液流变学的影响。方法:抽取2015年7月至2017年5月本院收治的120例冠心病患者,均行PCI术,按电脑数字表法随机分组,每组各60例,对照组施予常规治疗,实验组于此基础施予比索洛尔联合丹参多酚酸盐治疗,对比分析两组微炎环境及血液流变学等。结果:治疗后,实验组超敏C反应蛋白(hypersensitive C-reactive protein,hs-CRP)、TNF-α、脂蛋白相关磷脂酶A2(lipoprotein-associated phospholipase A2,Lp-PLA2)、血清可溶性细胞间粘附分子-1(soluble intercellular adhesion molecule-1,sICAM-1)、单核细胞Toll样受体4(Toll-like receptors 4,TLR4)及可溶性血管细胞间黏附分子-1(soluble vascular cell adhesionmolecula-1,sVCAM-1)低于对照组,差异有统计学意义(P<0.05);实验组红细胞压积、全血高切粘度、纤维蛋白原、全血低切粘度、红细胞聚集指数及血浆粘度均比对照组低,而红细胞变性指数比对照组高,差异有统计学意义(P<0.05);实验组左室舒张末期内径及左室收缩末期内径均比对照组低,而左室射血分数比对照组高,差异有统计学意义(P<0.05)。实验组单核细胞趋化蛋白-1(MCP-1)、生长分化因子15(GDF-15)浓度及血凝素样氧化型低密度脂蛋白受体-1(LOX-1)水平均比对照组低,而内脏脂肪特异性丝氨酸蛋白酶抑制剂(Vaspin)水平比对照组高,差异有统计学意义(P<0.05)。结论:比索洛尔联合丹参多酚酸盐有助于改善冠心病PCI术后患者微炎环境、血液流变学及心功能指标,值得推广。

关键词: 比索洛尔, 丹参多酚酸盐, 冠心病, PCI, 微炎环境, 血液流变学

Abstract:

AIM: To analyze the influence of bisoprolol combined with salvianolate on the inflammatory microenvironment and hemorheology indexes of patients with coronary heart disease after percutaneous coronary intervention (PCI). METHODS: Totally 120 cases of patients with coronary heart disease treated in our hospital from July, 2015 to May, 2017 who underwent PCI were randomly divided into control group and experimental group according to computer-generated number table method, with 60 cases in each group. The patients in control group were given conventional treatment, and the patients in experimental group were administered bisoprolol combined with salvianolate on that basis. The inflammatory microenvironment and hemorheology indexes of the patients in both groups were comparatively analyzed. RESULTS:After treatment, the levels of hypersensitive C-reactive protein (hs-CRP), TNF-α, lipoprotein-associated phospholipase A2 (Lp-PLA2), soluble intercellular adhesion molecule-1 (sICAM-1), Toll-like receptors 4 (TLR4) and soluble vascular cell adhesionmolecula-1 (sVCAM-1) in experimental group were all lower than those in control group, with statistically significant (P<0.05). The hematokrit, whole blood high shear viscosity, fibrinogen, whole blood low shear viscosity, erythrocyte aggregation index as well as plasma viscosity in experimental group were all lower than those in control group, while the erythrocyte deformation index was higher, with statistically significant (P<0.05). Both the left ventricular end diastolic diameter and the left ventricular end systolic diameter in experimental group were lower than those in control group, whereas the left ventricular ejection fraction showed the opposite response, with statistically significant (P<0.05). The levels of monocyte chemoattractant protein-1 (MCP-1), growth differentiation factor-15 (GDF-15) and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the experimental group were all lower than those in control group, while the level of visceral adipose tissue- derived serine protease inhibitor (Vaspin) in the experimental group was higher than that of the control group, with statistically significant (P<0.05). CONCLUSION:The combination of bisoprolol and salvianolate is conducive to improving the inflammatory microenvironment, hemorheology and cardiac function indexes of patients with coronary heart disease after PCI, and is worthy to be popularized.

Key words: bisoprolol,   salvianolate, coronary heart disease, PCI, inflammatory microenvironment, hemorheology indexes

中图分类号: